Women farmers’ inequalities on the rise as global hunger intensifies
HQ Team April 14, 2023: Women, who account for one-third of those employed in the agricultural sector, are paid about 20% less than.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team April 14, 2023: Women, who account for one-third of those employed in the agricultural sector, are paid about 20% less than.
HQ Team April 14, 2023: SAB Biotherapeutics got a fast-track designation from the USFDA for its investigational drug to treat influenza in high-risk.
HQ Team April 14, 2023: New safety warnings will be required on prescription labels for opioid pain relievers to prevent addiction and overdose,.
HQ Team April 13, 2023: Alphabet Inc, Google’s parent company, has signed two new power purchase agreements in Belgium and the Netherlands to.
HQ Team April 11, 2023: Astec LifeSciences, a subsidiary of Godrej Agrovet, opened its research and development centre in Rabale, Maharashtra, India, to.
HQ Team April 10, 2023: Cipla Ltd has agreed with Novartis Pharma AG to market and manufacture the Swiss-based company’s Galvus brand for.
HQ Team April 9, 2023: Suicides in Indiana, US, happens largely during the week of a full moon, between three and four in.
HQ Team April 8, 2023: Cancer vaccines will be ready by the end of this decade, according to pharmaceutical company Moderna’s chief medical.
HQ Team April 8, 2023: India’s federal government has told state authorities to identify emergency COVID-19 hotspots and ramp up testing, vaccination, and.
HQ Team April 7, 2023: The FDA has withdrawn Netherland-based Covis Pharma’s drug meant to cut preterm birth as it failed to prove.